[Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]

Secco A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32015000880
Spanish
Authors' recommendations: Even though there is little evidence of moderate methodological quality showing that the use of the nucleic acid amplification technique (NAT) is effective for screening of human immunodeficiency virus, hepatitis C virus and hepatitis B virus within the window period, the extent of the benefits of its routine use in blood samples from donors has not been clarified yet. Although NAT is widely used around the world and many international guidelines and standards recommend it, its implementation is not mandatory in many other countries. The World Health Organization still does not recommend it as a routine practice for all the countries, specially because it is considered that the potential benefits of its application are low when compared with its high cost. Its use might be accounted for in settings with a higher prevalence or incidence of blood borne infections.
Details
Project Status: Completed
Year Published: 2015
URL for published report: www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Nucleic Acid Amplification Techniques
  • Hepacivirus
  • Hepatitis B virus
  • Mass Screening
  • Blood Donors
  • HIV-1
  • Hepatitis C
  • Molecular Diagnostic Techniques
  • Sensitivity and Specificity
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.